Research

lf0 Research Notes

Get future lf0 equity research notes by email.

Weekly stock analysis, SEC filing-change summaries, and quant strategy notes from lf0.

Subscribe to lf0 Research Notes

Equity Research
KRP
Kimbell Royalty Partners Stock Analysis: Buy or Sell? Valuation, EBITDA & Leverage
Jul 17, 2026
Kimbell Royalty Partners LP (KRP) is rated Hold as its royalty model remains attractive, but a sharp drop in Q1 2026 EBITDA signals softer operating momentum. The key watchpoint is whether cash flow stabilizes above recent levels, while leverage and commodity sensitivity still limit upside.
Read note
Equity Research
NOVT
Novanta Stock Analysis: Buy or Sell? Valuation, FCF & Margins
Jul 17, 2026
Novanta (NOVT) is rated Hold as its net cash balance sheet and 8.7% free cash flow margin are offset by a 5.2x EV/revenue multiple and 36.1x forward P/E. Q1 2026 revenue rose 10.4%, but earnings still declined, leaving the stock priced for cleaner execution than the latest results support.
Read note
SEC What Changed
CULP, FEIM, PAYX
Culp (CULP) 10-K Changes Lead 17 July 2026 Filing Roundup
Jul 17, 2026
Culp (CULP) led the biggest 10-K filing change among 3 companies that filed annual reports on 17 July 2026, each compared against its prior-year 10-K.
Read note
Equity Research
FORM
FormFactor Stock Analysis: Buy or Sell? Valuation, Margin Reset & AI Demand
Jul 16, 2026
FormFactor (FORM) is rated Hold as strong AI-linked demand is offset by a valuation that already prices in much of the recovery. Q1 2026 showed revenue growth, but EBITDA softened and levered free cash flow still needs to improve before the upside case looks cleaner.
Read note
Equity Research
SANM
Sanmina Stock Analysis: Buy or Sell? Growth, Cash Flow & Margins
Jul 16, 2026
Sanmina Corp. (SANM) carries a Hold rating as revenue growth accelerates, but free cash flow remains negative and margins are still too thin to confirm a durable rerating. The key debate is whether higher-value mix can turn scale into self-funding earnings.
Read note
SEC What Changed
GDST
Chi Special Acquisition (GDST) 2026 10-K Analysis: MD&A Changes
Jul 16, 2026
Chi Special Acquisition (GDST) 2026 10-K analysis comparing the 16 July 2026 filing with its prior-year 10-K, highlighting the MD&A section’s biggest changes.
Read note
Equity Research
NEM
Newmont Corporation Stock Analysis: Buy or Sell? Valuation, Gold Prices & FCF
Jul 15, 2026
Newmont Corporation (NEM) is rated Hold as its stock already discounts a strong gold-price backdrop. The balance sheet is solid and free cash flow is strong, but downside grows if bullion normalizes and margins compress.
Read note
Equity Research
UAN
CVR Partners Stock Analysis: Buy or Sell? Valuation, Cash Flow & Commodity Risk
Jul 15, 2026
CVR Partners, LP (UAN) earns a Buy rating thanks to its hard-to-replicate nitrogen assets and strong cash generation. Commodity price swings remain the main risk, especially after EBITDA weakened sharply in late 2025 before rebounding in Q1 2026.
Read note
SEC What Changed
CAG, CAHO, NKE
Nike (NKE) 10-K Changes Lead 15 July 2026 Filing Roundup
Jul 15, 2026
Nike (NKE) led the biggest 10-K filing change among 3 companies that filed annual reports on 15 July 2026, each compared against its prior-year 10-K.
Read note
Equity Research
OMC
Omnicom Stock Analysis: Buy or Sell? Valuation, Leverage & Margins
Jul 15, 2026
Omnicom Group Inc. (OMC) is rated Hold as merger-driven scale is offset by thin margins and elevated debt. The 22.0% free cash flow yield supports the stock, but integration execution and client concentration remain key risks.
Read note

Get future lf0 research notes by email.

Equity research, SEC filing-change summaries, and quant research — delivered when published. Free, no noise.

Subscribe to lf0 Research Notes

No spam. Unsubscribe anytime.